Malignant hypertensive retinopathy is associated with characteristic fundus findings that typically do not include proliferative retinal vascular changes. We present the case of a 34-year-old patient who had bilateral decreased vision and was found to have malignant hypertension with hypertensive retinopathy changes along with unforeseen bilateral neovascularization and vitreous hemorrhage. Detailed history and extensive systemic and ophthalmic workup failed to reveal an alternative explanation for her proliferative retinopathy. Blood pressure control and panretinal photocoagulation halted further deterioration. Malignant hypertensive retinopathy can rarely cause profound retinal ischemia leading to retinal neovascularization. This case further supports the presence of “proliferative hypertensive retinopathy” that needs to be identified and addressed urgently through collaboration between internists and ophthalmologists.
Case Rep Ophthalmol 2021;12:594–602

中文翻译：

---

高血压作为增殖性视网膜病变的一个不寻常原因：病例报告和文献回顾

恶性高血压视网膜病变与特征性眼底表现有关，这些表现通常不包括增殖性视网膜血管变化。我们介绍了一名 34 岁患者的病例，该患者双侧视力下降，被发现患有恶性高血压，伴有高血压性视网膜病变，以及不可预见的双侧新生血管形成和玻璃体出血。详细的病史和广泛的全身和眼科检查未能揭示她增殖性视网膜病变的替代解释。血压控制和全视网膜光凝术阻止了进一步恶化。恶性高血压性视网膜病变很少会引起严重的视网膜缺血，导致视网膜新生血管形成。
Case Rep Ophthalmol 2021；12:594–602